SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11571763
Source:
http://linkedlifedata.com/resource/pubmed/id/11571763
Search
Subject
(
47
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0002395
,
umls-concept:C0016967
,
umls-concept:C0030705
,
umls-concept:C0034656
,
umls-concept:C0178602
,
umls-concept:C1707455
pubmed:issue
9
pubmed:dateCreated
2001-9-25
pubmed:abstractText
To investigate whether Galantamine significantly improves the core symptoms of Alzheimer's disease (AD).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8710629
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cholinesterase Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Galantamine
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0885-6230
pubmed:author
pubmed-author:MurrayJJ
,
pubmed-author:WilkinsonDD
pubmed:copyrightInfo
Copyright 2001 John Wiley & Sons, Ltd.
pubmed:issnType
Print
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
852-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11571763-Aged
,
pubmed-meshheading:11571763-Alzheimer Disease
,
pubmed-meshheading:11571763-Cholinesterase Inhibitors
,
pubmed-meshheading:11571763-Cognition Disorders
,
pubmed-meshheading:11571763-Disease Progression
,
pubmed-meshheading:11571763-Dose-Response Relationship, Drug
,
pubmed-meshheading:11571763-Double-Blind Method
,
pubmed-meshheading:11571763-Female
,
pubmed-meshheading:11571763-Galantamine
,
pubmed-meshheading:11571763-Humans
,
pubmed-meshheading:11571763-Male
,
pubmed-meshheading:11571763-Mental Status Schedule
,
pubmed-meshheading:11571763-Treatment Outcome
pubmed:year
2001
pubmed:articleTitle
Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease.
pubmed:affiliation
Old Age Psychiatry, Thornhill Research Unit, Moorgreen Hospital, Southampton, UK. dwilk2000@aol.com
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't